Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Drepadom - Home Care Services and Hospitalizations for Sickle Cell Disease Patients during the Covid-19 Pandemic

Gonzalo De Luna, Nicolas Lemonier, MD, Alexis Aidan, MD, Lea Bontemps, MD, Manuel Hautefaye, MD, Hadrien Diakonoff, MD, Cecile Aubrun, Anne-Laure Pham Hung D'Alexandry D'Orengiani, PhD, Dora Bachir, MD, Françoise Driss, MD, Amna Jebali, MD, Anoosha Habibi, MD PhD, Pablo Bartolucci, MD PhD

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-142796

Published: 2020

Journal Articles

Is There a Clinical Benefit to Switch Hydroxyurea (HU) Drug in Sickle Cell Disease (SCD)?

Frédéric Galactéros, MDPhD, Ersi Voskaridou, Anoosha Habibi, MD PhD, Giovanna Cannas, MD, Laure Joseph, MD, Gylna Loko, MD, Mariane De Montalembert, MD PhD, Narcisse Elenga, MD PhD, Malika Benkerrou, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-140265

Published: 2020

Journal Articles

Effect of Hydroxyurea Exposure before Puberty on Sperm Parameters in Males with Sickle Cell Disease

Laure Joseph, MD, Sandra Manceau, PhD, Corinne Pondarré, MD PhD, Anoosha Habibi, MD, Francoise Bernaudin, MD, Slimane Allali, MD, Mariane De Montalembert, MD, Céline Chalas, MD, Jean Benoît Arlet, MD PhD, Camille Jean, MD, Valentine Brousse, MD PhD

Blood (2019) 134 (Supplement_1): 889.

https://doi.org/10.1182/blood-2019-124950

Published: 2019

Journal Articles

A New Tool for HbF Quantification Demonstrates That Hydroxyurea Decreases Mostly RBCs Containing Very Low Amounts of HbF

Rakotoson Marie Georgine, Marie Cambot, Gwellaouen Bodivit, Gaetana Di Liberto, PhD, Philippe Chadebech, Nicolas Hebert, Benoit Vingert, PhD, Anoosha Habibi, MD, Sadaf Pakdaman, Alicia Jouard, France Pirenne, MD PhD, Frédéric Galactéros, MDPhD, Pablo Bartolucci, MD PhD

Blood (2017) 130 (Supplement 1): 3527.

https://doi.org/10.1182/blood.V130.Suppl_1.3527.3527

Published: 2017

Journal Articles

Outcome of Severe Vaso Occlusive Crisis in Sickle Cell Disease Adults Admitted to Referral Centers in Africa and Europe. Preliminary Results from the Presev 2 Study

Dapa Diallo, Prof, Mehdi Khellaf, Gonzalo De Luna, Sandrine Dautheville, Louis Affo, Stephanie Ngo, MD, Tatiana besse-Hammer, Yvon Segbena, jean Benoit Arlet, François Lionnet, Sylvain le-Jeune, Anoosha Habibi, MD, Bertrand Godeau, Frédéric Galactéros, MDPhD, Pablo Bartolucci, MD PhD

Blood (2017) 130 (Supplement 1): 3529.

https://doi.org/10.1182/blood.V130.Suppl_1.3529.3529

Published: 2017

Journal Articles

Management of Male Fertility in Sickle Cell Disease before and after Hydroxycarbamide

Anoosha Habibi, MD, Elena Foïs, MD, Giovanna Cannas, MD, Jean-Antoine Ribeil, MD, Pierre Cougoul, MD, Emmanuelle Bernit, MD, Pablo Bartolucci, MD PhD, Frederic Galacteros, MDPhD

Blood (2017) 130 (Supplement 1): 2260.

https://doi.org/10.1182/blood.V130.Suppl_1.2260.2260

Published: 2017

Journal Articles

Hydroxycarbamide (HU), Sickle Cell Disease and Pregnancy, a Multicentric Retrospective Study

Laure Joseph, MD, Anoosha Habibi, MD, Giovanna Cannas, MD, Stephanie Ngo, MD, Sylvain Le Jeune, MD, Ersi Voskaridou, MD, Elena Foïs, MD, Caroline Makowski, MD, Nathalie Lemonne, MD, Narcisse Elenga, MD, Yves Ville, MD PhD, Alexandra Benachi, MDPhD, Robert Girot, MD, Marina Cavazzana, MD PhD, Jean-Antoine Ribeil, MD PhD

Blood (2016) 128 (22): 1309.

https://doi.org/10.1182/blood.V128.22.1309.1309

Published: 2016

Journal Articles

The Use Of Rituximab For Preventing Delayed Haemolytic Transfusion Reaction In Highly Immunized Patients With Sickle Cell Disease

France Noizat-Pirenne, MD-PhD, Marc Michel, IV, Armand Mekontso-Dessap, Constance Guillaud, Keyvan Razazi, Matthieu Mahévas, Sadaf Pakdaman, Frederic Galacteros, MD PhD, Pablo Bartolucci, MD, PhD, Anoosha Habibi, MD

Blood (2013) 122 (21): 1162.

https://doi.org/10.1182/blood.V122.21.1162.1162

Published: 2013

Journal Articles

Biological Parameters Predictive Of Percent Dense Red Blood Cell Decrease Under Hydroxyurea Therapy

Marie Georgine Rakotoson, PhD student, Gaetana Di Liberto, PhD, Anoosha Habibi, MD, Christine Fauroux, Clinical Research Associate, Sanam Khorgami, Master Student, Dora Bachir, MD, France Noizat-Pirenne, MD-PhD, Frederic Galacteros, MD PhD, Pablo Bartolucci, MD-PhD

Blood (2013) 122 (21): 990.

https://doi.org/10.1182/blood.V122.21.990.990

Published: 2013

Journal Articles

Oral Chelator Deferiprone in Adult with Sickle Cell Disease.

Ruben Nzouakou, MD, Anoosha Habibi, MD, Ketty Lee, Alain Luciani, Jean-François Deux, Frederic Galacteros, Dora Bachir, MD

Blood (2009) 114 (22): 4615.

https://doi.org/10.1182/blood.V114.22.4615.4615

Published: 2009

Journal Articles

Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease Patients: Evidence of An Emerging Syndrome with Suicidal Erythrocyte Death

France Noizat-Pirenne, MD, PhD, Philippe Chadebech, PhD, Anoosha Habibi, MD, Dora Bachir, MD, Ruben Nzouakou, MD, Frederic Galacteros, MD, PhD, Philippe Bierling, MD, PhD

Blood (2008) 112 (11): 3037.

https://doi.org/10.1182/blood.V112.11.3037.3037

Published: 2008

Journal Articles

A Severe Case of Delayed Haemolytic Transfusion Reaction in a Sickle Cell Disease Patient: Immuno-Haematological Study, Cytokine Transcripts and Lymphocyte Subsets Analysis.

France Noizat-Pirenne, MD, PhD, Helene Ansart-Pirenne, MD, PhD, Anne Plonquet, MD, PhD, Philippe Chadebech, PhD, Anoosha Habibi, MD, Dora Bachir, MD, Frederic Galacteros, MD, PhD, Philippe Bierling, MD, PhD

Blood (2005) 106 (11): 954.

https://doi.org/10.1182/blood.V106.11.954.954

Published: 2005

Journal Articles

Treatment with rhEPO Decreases the Need for Transfusion in Patients with βThalassemia.

Dora Bachir, MD, Anoosha Habibi, MD, Serge Pissard, MD, Zohra Ourabah, MD, Frederic Galacteros, MD-PhD

Blood (2004) 104 (11): 3778.

https://doi.org/10.1182/blood.V104.11.3778.3778

Published: 2004

NARROW

Drepadom - Home Care Services and Hospitalizations for Sickle Cell Disease Patients during the Covid-19 Pandemic

Is There a Clinical Benefit to Switch Hydroxyurea (HU) Drug in Sickle Cell Disease (SCD)?

Effect of Hydroxyurea Exposure before Puberty on Sperm Parameters in Males with Sickle Cell Disease

A New Tool for HbF Quantification Demonstrates That Hydroxyurea Decreases Mostly RBCs Containing Very Low Amounts of HbF

Outcome of Severe Vaso Occlusive Crisis in Sickle Cell Disease Adults Admitted to Referral Centers in Africa and Europe. Preliminary Results from the Presev 2 Study

Management of Male Fertility in Sickle Cell Disease before and after Hydroxycarbamide

Hydroxycarbamide (HU), Sickle Cell Disease and Pregnancy, a Multicentric Retrospective Study

The Use Of Rituximab For Preventing Delayed Haemolytic Transfusion Reaction In Highly Immunized Patients With Sickle Cell Disease

Biological Parameters Predictive Of Percent Dense Red Blood Cell Decrease Under Hydroxyurea Therapy

Oral Chelator Deferiprone in Adult with Sickle Cell Disease.

Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease Patients: Evidence of An Emerging Syndrome with Suicidal Erythrocyte Death

A Severe Case of Delayed Haemolytic Transfusion Reaction in a Sickle Cell Disease Patient: Immuno-Haematological Study, Cytokine Transcripts and Lymphocyte Subsets Analysis.

Treatment with rhEPO Decreases the Need for Transfusion in Patients with βThalassemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only